• About us
• Contact

Advertisement

Organisation › Details

Forbion, Boston Office

June 2024, Forbion, a leading global life sciences venture capital firm with deep expertise in Europe, has hired former Dyne Therapeutics (“Dyne”) President and CEO Josh Brumm as a General Partner and is opening an office in Boston, Massachusetts. *

 

	Start	2024-06-27 established
	Group	Forbion (Group)
	Industry	venture capital
	Industry 2	LIFE SCIENCES
	Person	Brumm, Joshua (Josh) (Forbion 202406– General Partner before Dyne Tx + Kaleido Biosciences + Versartis + Pharmacyclics)
	Region	Boston, MA
	Country	United States (USA)
	Street	200 Clarenden Street 22nd Floor
	City	02116 Boston, MA
		Address record changed: 2024-10-19
Basic data	Employees	n. a.
		* Document for »About Section«: Forbion Capital Partners. (6/27/24). "Press Release: Forbion Strengthens US Presence, Hiring Biotech Industry Leader and Opening Boston Office". Naarden.
		Record changed: 2025-03-04

Advertisement

More documents for Forbion (Group)

• [1] Forbion Capital Partners. (1/27/25). "Press Release: Forbion BioEconomy Fund I Surpasses €150 Million Target, Raising €164.5 Million with Strong Institutional LP Support". Naarden....
• [2] Forbion Capital Partners. (1/13/25). "Press Release: Forbion Promotes Dirk Kersten to Managing Partner and Strengthens US Team". Naarden....
• [3] Orbis Medicines ApS. (1/6/25). "Press Release: Orbis Medicines Raises EUR 90 Million Series A Funding Round to Develop Pipeline of Oral Macrocycles". Copenhagen....
• [4] Forbion Capital Partners. (10/15/24). "Press Release: Forbion Raises in Excess of €2 Billion for Two New Funds". Naarden....
• [5] LoQus23 Therapeutics Ltd.. (10/2/24). "Press Release: LoQus23 Therapeutics Announces £35 Million (c.$43 Million) Series A Financing to Advance Its Small Molecule Somatic Expansion Inhibition Therapy for Huntington’s Disease". Cambridge....
• [6] AIRNA Corporation. (7/31/24). "Press Release: AIRNA Raises Oversubscribed $60 Million Financing to Advance New Class of RNA Editing Medicines and Progress Best-in-Class AATD Program into the Clinic". Cambridge, MA & Tübingen....
• [7] Forbion Capital Partners. (6/27/24). "Press Release: Forbion Strengthens US Presence, Hiring Biotech Industry Leader and Opening Boston Office". Naarden....
• [8] Forbion Capital Partners. (6/20/24). "Press Release: Forbion Announces First Close of Its New BioEconomy Fund I – Backing Biotech-enabled Companies Aiming to Impact the Future of Our Planet". Amsterdam....
• [9] NewAmsterdam Pharma Company N.V.. (4/1/24). "Press Release: NewAmsterdam Pharma Announces the Appointment of Juliette Audet as Chief Business Officer". Naarden & Miami, FL....
• [10] Mariana Oncology Inc.. (9/7/23). "Press Release: Mariana Oncology Announces $175 Million Series B Financing". Watertown, MA....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2025. Made in Germany.